Abstract:Blood–brain barrier (BBB) disruption occurs early enough to be within the thrombolytic time window, and this early ischemic BBB damage is closely associated with hemorrhagic transformation and thus emerging as a promising target for reducing the hemorrhagic complications of thrombolytic stroke therapy. However, the mechanisms underlying early ischemic BBB damage remain poorly understood. Here, we investigated the early molecular events of ischemic BBB damage using in vitro oxygen–glucose deprivation (OGD) and in vivo rat middle cerebral artery occlusion (MCAO) models. Exposure of bEND3 monolayer to OGD for 2 h significantly increased its permeability to FITC-labeled dextran and promoted the secretion of metalloproteinase-2 and -9 (MMP-2/9) and cytosolic translocation of caveolin-1 (Cav-1). This same OGD treatment also led to rapid degradation of tight junction protein occludin and dissociation of claudin-5 from the cytoskeleton, which contributed to OGD-induced endothelial barrier disruption. Using selective MMP-2/9 inhibitor SB-3CT (2-[[(4-phenoxyphenyl)sulfonyl]methyl]-thiirane) or their neutralizing antibodies or Cav-1 siRNA, we found that MMP-2 was the major enzyme mediating OGD-induced occludin degradation, while Cav-1 was responsible for claudin-5 redistribution. The interaction between Cav-1 and claudin-5 was further confirmed by coimmunoprecipitation. Consistent with these in vitro findings, we observed fluorescence tracer extravasation, increased gelatinolytic activity, and elevated interstitial MMP-2 levels in ischemic subcortical tissue after 2 h MCAO. Moreover, occludin protein loss and claudin-5 redistribution were detected in ischemic cerebromicrovessels. These data indicate that cerebral ischemia initiates two rapid parallel processes, MMP-2-mediated occludin degradation and Cav-1-mediated claudin-5 redistribution, to cause BBB disruption at early stroke stages relevant to acute thrombolysis.

The Role of Metalloproteinases in the Development of Ischemia-Induced Pathologies of the Blood–Brain Barrier

Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia

Blood-Brain Barrier Breakdown In Acute And Chronic Cerebrovascular Disease

Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke

Oxidative Stress and Blood–Brain Barrier Dysfunction Under Particular Consideration of Matrix Metalloproteinases

Molecular Insights and Therapeutic Targets for Blood–brain Barrier Disruption in Ischemic Stroke: Critical Role of Matrix Metalloproteinases and Tissue-Type Plasminogen Activator

Research Progress of Mechanisms for Tight Junction Damage on Blood–brain Barrier Inflammation

Multiple roles of metalloproteinases in neurological disorders.

Blood-Brain Barrier Protection as a Therapeutic Strategy for Acute Ischemic Stroke

The Role of Ferroptosis in Blood-Brain Barrier Injury

The Blood Brain Barrier in Cerebral Ischemic Injury – Disruption and Repair

Vasogenic Edema Due to Tight Junction Disruption by Matrix Metalloproteinases in Cerebral Ischemia.

The role of platelets in the blood-brain barrier during brain pathology

Matrix Metalloproteinase-Mediated Disruption of Tight Junction Proteins in Cerebral Vessels is Reversed by Synthetic Matrix Metalloproteinase Inhibitor in Focal Ischemia in Rat.

Matrix Metalloproteinases in Acute Intracerebral Hemorrhage

Matrix Metalloproteinases As Therapeutic Targets for Stroke

Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke

Targeting oxidative stress and inflammatory response for blood-brain barrier protection in intracerebral hemorrhage

Matrix Metalloproteinase-2-Mediated Occludin Degradation and Caveolin-1-Mediated Claudin-5 Redistribution Contribute to Blood–Brain Barrier Damage in Early Ischemic Stroke Stage

Biological significance and pathophysiological role of Matrix Metalloproteinases in the Central Nervous System

MMP-mediated Disruption of Claudin-5 in the Blood-Brain Barrier of Rat Brain after Cerebral Ischemia.